Rivia Raises €3M for AI Analytics Platform- Funds to Enhance Talent, Technology, and Sales

Rivia raises €3M in Seed Funding

Rivia (Linkedin), a Swiss startup specializing in AI-driven analytics and clinical trial data infrastructure, recently secured €3M in seed funding. Their platform simplifies data acquisition and analysis for biotech companies involved in clinical trials, with a focus on the European and US markets.

Funding Amount: €3 million

Industry: Software Development

Employee Count: 2-10

CEO: Erik Scalfaro (CEO Linkedin)

What Rivia needs to buy: Rivia is seeking partnerships with technology and AI experts, as well as marketing and sales service providers. Companies specializing in data infrastructure, analytics, and clinical research support are ideal partners for Rivia, as they can help enhance their platform's capabilities, expand their customer base, and increase market presence.